Caffeic Acid Phenethyl Ester Increases Radiosensitivity of Estrogen Receptor- Positive and -Negative Breast Cancer Cells by Prolonging Radiation-Induced DNA Damage

다국어 초록 (Multilingual Abstract)

Purpose: Breast cancer is an important cause of death among women. The development of radioresistance in breast cancer leads to recurrence after radiotherapy. Caffeic acid phenethyl ester (CAPE), a polyphenolic compound of honeybee propolis, is known to have anticancer properties. In this study, we examined whether CAPE enhanced the radiation sensitivity of MDAMB- 231 (estrogen receptor-negative) and T47D (estrogen receptor- positive) cell lines. Methods: The cytotoxic effect of CAPE on MDA-MB-231 and T47D breast cancer cells was evaluated by performing an 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) assay. To assess clonogenic ability, MDAMB- 231 and T47D cells were treated with CAPE (1 μM) for 72 hours before irradiation, and then, a colony assay was performed.
A comet assay was used to determine the number of DNA strand breaks at four different times. Results: CAPE decreased the viability of both cell lines in a dose- and time-dependent manner. In the clonogenic assay, pretreatment of cells with CAPE before irradiation significantly reduced the surviving fraction of MDA-MB-231 cells at doses of 6 and 8 Gy. A reduction in the surviving fraction of T47D cells was observed relative to MDA-MB-231 at lower doses of radiation. Additionally, CAPE maintained radiation-induced DNA damage in T47D cells for a longer period than in MDA-MB-231 cells. Conclusion: Our results indicate that CAPE impairs DNA damage repair immediately after irradiation. The induction of radiosensitivity by CAPE in radioresistant breast cancer cells may be caused by prolonged DNA damage.

참고문헌 (Reference)

1 Chavez KJ, "Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer" 32 : 35-48, 2010

2 Ozturk G, "The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers" 16 : 2064-2068, 2012

3 Li F, "Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy" 1805 : 167-180, 2010

4 Deorukhkar A, "Targeting inflammatory pathways for tumor radiosensitization" 80 : 1904-1914, 2010

5 Hagen KR, "Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis" 8 : 10-, 2013

6 Zoberi I, "Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines" 175 : 165-173, 2002

7 Jameel JK, "Radioresistance in carcinoma of the breast" 13 : 452-460, 2004

8 Omene C, "Propolis and its active component, caffeic acid phenethyl ester (CAPE), modulate breast cancer therapeutic targets via an epigenetically mediated mechanism of action" 5 : 334-342, 2013

9 Kang NJ, "Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis" 130 : 310-324, 2011

10 Rouhani M, "Lithium increases radiosensitivity by abrogating DNA repair in breast cancer spheroid culture" 17 : 352-360, 2014

11 Akyol S, "In vivo and in vitro antıneoplastic actions of caffeic acid phenethyl ester (CAPE): therapeutic perspectives" 65 : 515-526, 2013

12 Simeone AM, "HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR)in breast cancer cells by decreasing nitric oxide production" 22 : 6739-6747, 2003

13 Tanaka T, "Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity" 14 : 1266-1273, 2008

14 Ding J, "Emerging cancer therapeutic opportunities target DNA-repair systems" 27 : 338-344, 2006

15 Nambiar D, "Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy" 728 : 139-157, 2011

16 Thomas C, "ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR" 14 : R148-, 2012

17 Watanabe MA, "Cytotoxic constituents of propolis inducing anticancer effects: a review" 63 : 1378-1386, 2011

18 Franken NA, "Clonogenic assay of cells in vitro" 1 : 2315-2319, 2006

19 Holliday DL, "Choosing the right cell line for breast cancer research" 13 : 215-, 2011

20 Garg AK, "Chemosensitization and radiosensitization of tumors by plant polyphenols" 7 : 1630-1647, 2005

21 Chen MF, "Cell killing and radiosensitization by caffeic acid phenethyl ester (CAPE) in lung cancer cells" 45 : 253-260, 2004

22 Lee Y, "Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition" 643 : 21-28, 2010

23 Jung BI, "Caffeic acid phenethyl ester, a component of beehive propolis, is a novel selective estrogen receptor modulator" 24 : 295-300, 2010

24 Chen YJ, "Caffeic acid phenethyl ester preferentially sensitizes CT26 colorectal adenocarcinoma to ionizing radiation without affecting bone marrow radioresponse" 63 : 1252-1261, 2005

25 Lee YY, "Caffeic acid phenethyl ester preferentially enhanced radiosensitizing and increased oxidative stress in medulloblastoma cell line" 24 : 987-994, 2008

26 Natarajan K, "Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B" 93 : 9090-9095, 1996

27 Lin HP, "Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells" 7 : e31286-, 2012

28 Wu J, "Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer" 308 : 43-53, 2011

29 Weigelt B, "Breast cancer metastasis: markers and models" 5 : 591-602, 2005

30 Lin YH, "Antiproliferation and radiosensitization of caffeic acid phenethyl ester on human medulloblastoma cells" 57 : 525-532, 2006